Quantitative Analysis of Multiple Serum Tumor Biomarkers by an Interpretable Stacked Ensemble Model
Clinical Snapshot
PICO Framework
| P — Population | Serum samples containing tumor biomarkers (specific patient population not clearly defined) |
| I — Intervention | Surface-enhanced Raman spectroscopy (SERS) with interpretable stacked ensemble model (ISEM) |
| C — Comparator | Traditional machine learning models for SERS data analysis |
| O — Outcomes | Quantitative accuracy of 12 serum tumor biomarkers (R² values), sensitivity, specificity, and model interpretability |
Bottom Line
This analytical chemistry study demonstrates high technical performance of a novel SERS-based method for quantifying multiple tumor biomarkers using interpretable machine learning. While the analytical validation shows promise with R² values exceeding 0.9, the study lacks critical clinical validation elements. Key limitations include absence of diagnostic accuracy metrics (sensitivity, specificity), unclear reference standards, and no defined clinical population or utility. The interpretable AI component using SHAP analysis is innovative, but clinical translation requires validation against established biomarker assays in relevant patient populations. Australian clinicians should await clinical validation studies before considering implementation, as current evidence supports analytical but not clinical validity.
Key Findings
P Value: Not reported
Effect Size: R² values exceeding 0.9 for all biomarkers
Primary Outcome: Quantitative accuracy of 12 serum tumor biomarkers
Nnt Or Sensitivity: Sensitivity and specificity not reported
Confidence Interval: Not reported
Clinical Application
Limited by requirement for specialized SERS equipment and technical expertise Would require TGA approval as novel diagnostic device; unclear PBS funding eligibility without clinical utility data Unclear - patients requiring tumor biomarker screening, but specific indications not defined
Abstract
Surface-enhanced Raman spectroscopy (SERS) offers exceptional sensitivity and specificity for biomolecular detection, particularly in analyzing serum tumor biomarkers. However, its application is hindered by spectral complexity and matrix interference. Although machine learning (ML) has shown promise in SERS data analysis, existing quantitative models for biomarker detection lack generalizability and interpretability. To address these challenges, we developed an interpretable stacked ensemble model (ISEM) that integrates feature selection, ensemble learning, and explainable artificial intelligence (XAI) for quantifying 12 serum tumor biomarkers. To ensure reliable quantitative analysis, we validated the acquired SERS data using uniform and reproducible Au nanoparticle substrates. Preprocessing, least absolute shrinkage, and selection operator (LASSO) feature selection were employed to establish a foundation for accurate quantification. Subsequently, 12 serum tumor biomarkers were quantified, demonstrating the superior performance of ISEM, which achieved a high predictive accuracy, with R2 values exceeding 0.9 for all biomarkers. Crucially, based on the quantitative results, we provided molecular-level interpretability for structure-spectrum correlations using Shapley additive explanations (SHAP), revealing how glycosylation reactions, matrix interference, and spectral overlap influence prediction accuracy. Furthermore, the capability of ISEM to quantify multiple biomarkers in unseen samples was confirmed through validation of its generalizability. Our study establishes an ensemble-driven, interpretable framework for quantitative biomarker analysis in a complex biological matrix, demonstrating significant potential for early cancer diagnosis and screening.
References
- 1.Wu, B., Chen, J., Huang, Y., Li, P., Deng, Q., Dong, R., & Yang, L. (2026). Quantitative analysis of multiple serum tumor biomarkers by an interpretable stacked ensemble model. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.5c04589
Related Research
Bioorganic chemistry
In silico discovery and biological evaluation of a novel selective HDAC8 inhibitor featuring 1H-pyrazolo[3,4-b]pyridine scaffold
7 June 2026
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Multivariate feature analysis of early-stage laryngeal cancer serum components using surface-enhanced Raman spectroscopy
7 June 2026
Clinical chemistry and laboratory medicine
Automation in value-based laboratory medicine: driving precision, capacity, and better outcomes
26 May 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service